EUVIMEDEUVIMED entdecken
Crossref

Optimizing Antiviral Stockpiles for Pandemic Response: A Strategic Framework

Rick A Bright iD

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Rick A Bright. Beteiligte Einrichtung: Bright Global Health, Waterford, Virginia, USA. Hauptthemen laut MEDLINE: Antiviral Agents, Influenza, Human, Pandemics, Strategic Stockpile. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza antiviral stockpiling represents a critical component of pandemic preparedness, yet evolving challenges demand new approaches to this strategic imperative. The Strategic National Stockpile’s target of maintaining antiviral courses for 25% of the United States population reflects both economic modeling and practical experience from recent pandemics, including the 2009 influenza A(H1N1) and coronavirus disease-19 pandemics. This perspective examines the evolution of antiviral stockpiling strategies, highlighting key lessons from these events as well as challenges in supply chain resilience, resistance management, and rapid deployment. The increasing diversity of available antivirals, from traditional neuraminidase inhibitors to a newer cap-dependent endonuclease inhibitor and emerging host-targeted therapeutics, offers opportunities for more robust stockpiling strategies. However, this diversity also introduces complexities in decision-making, storage, and deployment. Recent advances in artificial intelligence and manufacturing technologies present promising solutions for enhancing stockpile management, potentially enabling more responsive just-in-time production capabilities. The integration of rapid diagnostics, streamlined distribution systems, and novel therapeutic approaches could transform traditional stockpiling paradigms. This analysis provides a framework for optimizing antiviral stockpiles that balances immediate pandemic response capabilities with long-term strategic considerations, while addressing critical challenges in resistance management, pediatric formulations, and supply chain resilience.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsInfluenza, HumanPandemicsStrategic StockpileHumansCOVID-19Influenza A Virus, H1N1 SubtypeSARS-CoV-2United States

Stichwörter der Autor:innen

antiviral resistance managementantiviral stockpilinginfluenzapandemic preparednesssupply chain resilience

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Bright Global Health, Waterford, Virginia, USA.

ORCID-Profile: Rick A Bright

Zitieren

APA

Bright, R. A. (2025). Optimizing Antiviral Stockpiles for Pandemic Response: A Strategic Framework. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf264

Vancouver

Bright RA. Optimizing Antiviral Stockpiles for Pandemic Response: A Strategic Framework. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf264

BibTeX
@article{Bright2025,
  author = {Bright, Rick A},
  title = {Optimizing Antiviral Stockpiles for Pandemic Response: A Strategic Framework},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf264}
}
Kostenlos starten →